Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH

43.05

+1.26(+3.02%)

Updated at December 05 02:24PM

Currency In CNY

Valuation

Market Cap8.08B
Enterprise Value8.96B
P/E Ratio-17.66
PEG Ratio-1.02
Price/Sales Ratio26.81
Price/Book Ratio21.99
Enterprise/Revenue28.71
Enterprise/EBITDA-22.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.52
Operating Margin-1.46

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.86

Income Statement

Revenue199.78M
Revenue/Share1.56
Gross Profit165.3M
EBITDA-930.36M
Net Income-1.04B
Diluted EPS-2.61

Balance Sheet

Total Cash1.48B
Total Cash/Share3.71
Total Debt2.63B
Total Debt/Equity3.45
Current Ratio0.9
Book Value Per Share2.37

Price History

52-Week Change68.61
52-Week High63.59
52-Week Low15.36
Moving Average 50 Days44.88
Moving Average 200 Days33.18

Statistics

Average Volume11.11M
Shares Outstanding399.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split FactorN/A
Last Split DateN/A